FDA Approves Unknown Drug — GRANULES

# FDA Approves Generic Drug Application for Granules India Granules India received FDA approval for ANDA213469 on April 24, 2020, positioning the company to capture additional market share in the generic pharmaceutical segment as patent protections expire on the reference drug. The approval strengthens Granules' portfolio of affordable generic medications and enhances its competitive standing in the U.S. market.